z-logo
open-access-imgOpen Access
Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure
Author(s) -
Zhihong Wan,
Jianjun Wang,
Shaoli You,
Hongling Liu,
Bing Zhu,
Zhigang Hong,
Chen Li,
Jing Chen,
Shaojie Xin
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i48.9432
Subject(s) - medicine , cystatin c , renal function , creatinine , acute kidney injury , gastroenterology , biomarker , chronic hepatitis , odds ratio , kidney disease , immunology , biochemistry , chemistry , virus
To investigate serum cystatin C level as an early biomarker for predicting acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here